WASHINGTON — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug ... begin covering the drug if it gets FDA’s full OK.

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (FDA) advisory panel on Monday. Donanemab is designed to treat symptoms of early Alzheimer’s ...

Washington – Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug ... begin covering the drug if it gets FDA’s full OK.

WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening ... will immediately begin covering the drug if it ...